Weekly News Recap #Phispers
Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon
In Phispers this week, two drugmakers emerging from bankruptcy — Mallinckrodt and Endo — are merging in order to le...
Impressions : 1328
Madrigal’s Rezdiffra becomes first FDA-approved drug to treat NASH; Astra buys Fusion for US$ 2.4 bn
It was a week of drug approvals, as the US Food and Drug
Administration (FDA) okayed several therapies before the close of the...
Impressions : 3039
Lilly to launch Zepbound in more markets this year; Casgevy bags second FDA nod
This week’s Phispers brings you news from the annual World Economic Forum in Davos (Switzerland) where some senior execut...
Impressions : 2123
J&J to spin off consumer biz within two years; Biden nominates Califf as FDA chief
After a gap of a week, Phispers is back with reports of some big developments in the world of pharmaceuticals. The biggest news...
Impressions : 1853
US plans to reduce drug manufacturing dependence on China, India; Cross-contamination problems at Cipla
This week, Phispers has more updates on Covid-19.
The US is preparing an executive order that will reduce the country’s...
Impressions : 2094
Covid-19 update: Indian firms airlift APIs from China; FDA suspends foreign inspections; pharma events get cancelled
This week, Phispers brings you more updates on the novel coronavirus, as the WHO declared its spread a pandemic.
The USFDA ha...
Impressions : 6942
EMA raises NDMA impurity concerns in diabetes drug made by Hetero; shareholder revolt rocks Bayer
This week, there is news on EMA telling companies using certain reagents to make diabetes drug — pioglitazone &mdash...
Impressions : 3982
Apotex’s founder was murdered, its president resigns; Daiichi to recover $551 million from Ranbaxy promoters
This week in Phispers, we bring you news on the Singh brothers, the former promoters of Ranbaxy, who lost a case in the Delhi h...
Impressions : 5903
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.